Drug Discovery News
Exosomes show encouraging results for treating melanoma, offering potential benefits for targeted drug delivery and immunotherapy
When Susanne Gabrielsson first learned about exosomes, her eyes widened. In 1999, she’d just started a postdoctoral fellowship at the Curie Institute in Paris. Gabrielsson, an immunologist now at Sweden’s Karolinska Institute, thumbed through paper after paper describing which types of cells release these tiny blobs of information.
“I realized that since they were released from many cells, they probably would be released from all cells,” she said. “And that they would be a new means of communication.”
Max G. Levy 